Pharmaceutical, biotechnology, and medical device manufacturers, as well as payers and providers, compete in a unique market setting. We combine expertise in antitrust and competition with extensive industry-specific experience to support clients in a variety of contexts. In recent years, challenging issues in antitrust have arisen from allegations involving:
- Product hopping
- Exclusive dealing
- Price discrimination
- Other exclusionary practices
Our experts have supported clients in a variety of high-profile health care matters, and our analysis of class certification, liability, and damages issues is distinguished by our knowledge of industry institutions and practices, FDA rules and governance, data sources, and analytical approaches. We have provided expert testimony in all phases of litigation and our work spans many different types of cases.
- Featured Expert David Dranove Walter J. McNerney Distinguished Professor of Health Industry Management; Professor of Management and Strategy, Kellogg School of Management, Northwestern University
U.S. et al. v. Anthem Inc. et al.
- Featured Expert Pierre Y. Cremieux President, Boston, Paris, Brussels, London, Montreal
Saint Alphonsus Medical Center - Nampa et al. v. St. Luke's Health System Ltd.
- Video Richard Mortimer - The Competitive Landscape for Biosimilars
Pre-Merger Investigation of Medtronic Acquisition